Devyser Diagnostics Ab Stock Price To Sales

DVYSR Stock   122.00  2.00  1.61%   
Devyser Diagnostics AB fundamentals help investors to digest information that contributes to Devyser Diagnostics' financial success or failures. It also enables traders to predict the movement of Devyser Stock. The fundamental analysis module provides a way to measure Devyser Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Devyser Diagnostics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Devyser Diagnostics AB Company Price To Sales Analysis

Devyser Diagnostics' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

 = 

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Devyser Diagnostics Price To Sales

    
  9.76 X  
Most of Devyser Diagnostics' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Devyser Diagnostics AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

Based on the latest financial disclosure, Devyser Diagnostics AB has a Price To Sales of 9.7558 times. This is 54.41% lower than that of the Healthcare sector and 15.97% lower than that of the Diagnostics & Research industry. The price to sales for all Sweden stocks is 14.57% higher than that of the company.

Devyser Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Devyser Diagnostics' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Devyser Diagnostics could also be used in its relative valuation, which is a method of valuing Devyser Diagnostics by comparing valuation metrics of similar companies.
Devyser Diagnostics is currently under evaluation in price to sales category among its peers.

Devyser Fundamentals

About Devyser Diagnostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Devyser Diagnostics AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Devyser Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Devyser Diagnostics AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Devyser Stock Analysis

When running Devyser Diagnostics' price analysis, check to measure Devyser Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Devyser Diagnostics is operating at the current time. Most of Devyser Diagnostics' value examination focuses on studying past and present price action to predict the probability of Devyser Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Devyser Diagnostics' price. Additionally, you may evaluate how the addition of Devyser Diagnostics to your portfolios can decrease your overall portfolio volatility.